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PREC URSOR - PRODUC T RELATIONSHIPS 
IN THYROIDAL IODOCOMPOUNDS 

IN TROD UC TION 
It is generally accepted that serum inorganic iodide con¬ 
centrated by the normal mammalian thyroid gland is rapidly and 
sequentially organified in thyroglobulin into first MIT and then 
DIT. MIT or DIT is then ‘coupled’ with DIT contained in thyro¬ 
globulin to produce, respectively, T^ or T^. These are subse¬ 
quently released by thyroidal proteases from storage thyroglobulin. 
Some of the evidence that has helped to form this consensus will 
be briefly reviewed. 
In 192 7 Harington and Barger (1) first suggested that 
thyroxine might arise from the coupling of two molecules of DIT 
with the elimination of an alanine side chain. Direct experimental 
support for this suggestion has been considerable (2). A theoret¬ 
ical model (3) for this oxidative conversion and experimental 
proof (4) that an oxidizing milieu was necessary for the in vitro 
reaction followed. 
Several hypotheses regarding mechanism of formation 
attended the 1952 discovery (5,6) of T^ in thyroid tissue. Pro¬ 
ponents (7) of the hypothesis that T_ was formed by intrathyroidal 
deiodination of T^ seemed to be disproved by the findings of Roche 
et al. (8) that thyroidal deiodinase could use only iodotyrosines and 
not thyroxine as a substrate. However, Pitt-Rivers and Tata later 
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asserted (9) that when thyroxine was separated from serum 
proteins it could be deiodinated by pig thyroid deiodinase. 
In another approach to the origin of T^, Plaskett (10,1 1) 
determined the distribution of I u on the two rings in and T^. 
From studies of rabbit thyroid tissue hydrolysed 24 hours after 
the injection of I he found that the activity was randomly 
distributed in each ring of the two compounds. He felt that his 
data were incompatible with the formation of from MIT and 
DIT as the labeling in the two rings would have been different 
unless there were equal activity in MIT and DIT at 24 hours, a 
circumstance he thought unlikely. (Data are not yet available on 
whether normal rabbit thyroid has reached isotopic equilibrium 
24 hours after I ° injection.) He concluded, therefore, that 
random labeling supported the hypothesis that T^ was produced 
by the deiodination of T^, but that a confident statement could 
not be made until specific activity data were determined for MIT 
and DIT. 
Precursor-product relationships among these latter com¬ 
pounds are as yet unclear. Michel (12), and later Pitt-Rivers 
1 Q 1 
and Tata (13), agree that injected I ° appears first in MIT and 
that as radioactivity in that compound declines the amount in DIT 
increases, and hence ‘MIT is the precursor of DIT.’ 
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Taurog, Tong and Chaikoff (14) investigating another 
13 1 phenomenon--the effect of hypophysectomy on I incorporation-- 
showed that in thyroid hydrolysates from their normal control 
rats Ml^^T activity was maximal and then began to fall off before 
radioactivity in DIT had reached its maximum and plateaued at 
that level. This and similar studies are cited as evidence that 
DIT arises from MIT, as the continuous formation of DI^ '^T 
would lead to decreasing amounts of MI . However, in contra¬ 
diction to these findings Bois and Lars son (15) reported that the 
DIT/MIT ratio in rat thyroid hydrolysates was constant during a 
period from 30 minutes to one week after the injection of I . 
They concluded, notwithstanding, that DIT was derived from the 
iodination of MIT, feeling that if there were any other precursors 
the proportion of MI^^T would have decreased with time. 
Although other workers have reached similar conclusions, the 
experimental findings of Bois and Lars son have not been substan¬ 
tiated. 
131 
Pitt-Rivers m studied I incorporation into MIT, 
DIT, Tg and T^ released by enzymatic hydrolysis from rat thy¬ 
roid glands, and computed the relative specific activities (RSA) 
of these compounds. She concluded that MIT and DIT satisfy the 
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criteria (17) for a precursor-product relationship. The conclus¬ 
ion was also drawn that both T and To are formed by a coupling 
4 ^ 
mechanism from the iodotyrosines, although data are presented 
that tend to show that the maximum RSA of T^ occurs before or 
at the same time as the maximum for MIT, and that the RSA 
curves of DIT and T likewise are similar in shape and time 
4 
course. 
Pitt-Rivers and Cavalieri (18) soon after indicated that 
the RSA of free MIT (dialysable at 0°C) exceeded that of bound 1 
MIT and the ‘second pool of inorganic iodide’ up to G hours after 
1 1 the injection of a single dose of I . They found the specific 
activity of free DIT to be lower than that of free or bound MIT. 
If true, these latter findings raise the interesting possi¬ 
bility that he explanation for the simultaneous maxima in the 
relative specific activities of bound MIT and T^ and bound DIT 
and T^ lies in the participation of the free iodotyrosines or 
related iodocompounds as well as bound MIT and DIT in hormone 
biosynthesis. 
In the experiments described here it was attempted to 
clarify the role played by the free iodocompounds reported by 
Pitt-Rivers and Cavalieri (18), Lissitzky et air (19), and 
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Lissitzky and Haney (20) in the biosynthesis of the thyroid 
hormones by determining their relative specific activities. The 
free iodocompounds under investigation include, in addition to MIT 
and DIT (18,19,20) various iodopeptides that have been partially 
characterized in earlier communications from Lissitzky’s group 
(19,20). Other free iodocompounds, including MIHPPA and 
DIHPPA, which have been described (21) in thyroidal tissue 
were not investigated in the present work^. 
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MATERIAL AND METHODS 
White rats of the Wistar strain were fed on a diet of 
standard animal biscuit and bread with no special precaution to 
obtain a low-iodine diet. Males weighing 100-140 grams were 
1 <3 1 
injected intraperitonea lly with carrier-free Nal (Commis¬ 
sariat a l’Energie Atomique, Saclay, Seine et Oise, France), 
killed by a blow on the head, and their thyroids taken according 
to the protocol in Table I. 
TABLE I. 
PROTOCOL FOR NAI131 INJECTION OF ANIMALS 
Interval between Number Nal131 
Nal*3* injection and of rats injected/animal 
thyroid dissection microcuries 
0.5 3 200 
1 4 100 
3 3 150 
6 3 100 
8 5 100 
11 4 100 
15 4 100 
20 4 100 
24 2 50 
30 4 100 
50 2 50 
72 3 100 
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Pooled thyroid glands of each group were weighed and 
their radioactivity determined using a well-crystal scintillation 
counter that maintained a constant geometry and efficiency,, 
Each group of pooled thyroids was then put into a dialysis 
sac (Visking cellulose tubing 20/32) and dialysed 24 hr against 
100 ml of precooled water at 0°C. The introduction of glands 
into the sac was done through a small funnel in order to avoid any 
contact of glands with the upper part of the sac and therefore to 
eliminate possible contamination of the dialysate with traces of 
I1 ^ 1-thyroglobulin remaining on the walls of the sac. This point 
is important in view of the small percentage of total I repre¬ 
sented by the dialysate. The tubing was then double knotted at 
both ends in such a fashion as to eliminate most air bubbles and 
to leave between the double knots at each end a short length of 
tube that would provide a visual check as to whether the inner 
knots had leaked. The ends were then joined to give the final sac 
a ring form. 
Pilot experiments with an apparatus that replaced with 
fresh precooled water the dialysate volume of 1 ml every 9 
minutes and collected the effluent dialysate in fractions of 5 ml, 
showed the curve in Figure 1 as a function of time and volume 
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10 20 30 
n° of Fractions ( 5 mC ) 
Figure 1. Continuous dialysis at a constant rate of 
1 ml/9 minutes of 1*31 labeled rat thyroid glands (24 hours) 
against precooled water. Ordinate: cumulative radioactivity 
in the dialysate (counts/minute). 
On this basis, it was assumed that at least 95% of the 
non-protein bound iodine had passed into the dialysate at 24 
hours. Free and do not normally diffuse out in dialysis 
against water, these compounds being weakly soluble and 
strongly bound to thyroglobulin and other proteins. They 
dialyze out against human serum (20). 
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As the relative percentages of the iodocompounds 
dialyzed remained constant after the first 4-8 hours, it was 
assumed that the several per cent of free activity that remained 
in the glands after 24 hours did not constitute one sole compound 
but was distributed as in the dialysate. 
After counting, the dialysates were concentrated under 
reduced pressure at a temperature lower than 40°C in a rotary 
evaporator until almost dry (volume about 0,5 ml). They were 
2 
then transferred to a 1 cm origin spot on whole sheets of 
Whatman No. 1 chromatographic paper (47 X 56 cm). Five 
micrograms each of MIT, DIT, Tg and T^ were added as carriers 
and descending chromatography in 1-butanol-acetic acid-water 
(78:5:17) was performed along the short dimension of the paper 
up to the opposite edge (17-18 hours at 18°C). 
Developed chromatographs were air-dried at room 
temperature until no odor of acetic acid could be detected and 
trimmed to a width of 40 cm in the direction corresponding to 
chromatography. 
Electrophoretic migration at right angles to the chromato¬ 
graphic direction was carried out in pyridine-acetic acid-water 
buffer (1:10:289, pH 3.65) according to Katz, Dreyer, and 
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Anfinsen (23) in an apparatus constructed in the laboratory 
according to the plans of these authors and supplied by the 
engineering staff of the National Institutes of Health, Bethesda, 
Maryland. 
5 
Dilutine 140 was used as a coolant and as a heat- 
transfer medium to the running water which circulated in stainless 
steel cooling coils. The considerable volume of the buffer (30 1) 
and the Dilutine (35 1) and convection currents in the coolant 
prevented problems due to overheating during electrophoresis. 
Chromatographs, prepared as described above, were 
evenly wetted with the pyridine buffer by spraying with an atomizer. 
The origin and line of chromatographic migration were not directly 
wetted but allowed to imbibe from either wetted side, so as to 
concentrate the chromatographically separated products into a 
tighter band. If the origin would not wet in this manner, a drop of 
buffer was directly applied, for areas of the paper not wetted by 
the buffer will be wetted by the Dilutine coolant resulting in trailing 
and faulty migration. After 2 hours of electrophoresis at 2500 volts 
(average current for 40-cm wide Whatman No. 1 paper was 65-70 
milliamperes), the paper was air-dried and then warmed in a 45°C 
oven to drive off traces of pyridine and acetic acid. It was then 
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autographed for 7-8 days on Kodak no-screen X-ray film (30 X 
40 cm) with the paper sandwiched between two sheets of film and 
stapled. Position of the staples served to align paper and films 
for the procedure described below. 
Areas of the chromatoelectrophoretograms corresponding 
to spots revealed on the films (Figure 4) were cut out and counted 
in a well-type scintillation spectrometer with automatic sample 
changing, permitting long enough counting times (60-120 minutes in 
certain cases) to achieve a statistical error of apporximately 1%. 
Two areas of the paper taken in a region devoid of film- 
detectible radioactivity (blanks) were counted for the same time 
and their mean radioactivity was subtracted from that of areas 
corresponding to each radioactive spot. 
The rest of the paper, i.e., that part not corresponding to 
any definite spot was then cut into convenient pieces and counted 
in the same manner to determine the total radioactivity on the 
paper. The percentage of inorganic iodide in the dialysate was 
determined by unidimensional electrophoresis and counting, after 
radio-autography, in the same fashion. 
After dialysis, the thyroid tissue was ground with glass 
powder and hydrolyzed with pancreatin (Viobin 4X USP) added 
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in a weight ratio of 1:20 in 0.2 M NII^HCOg, pH 8.6, for 24 hours 
at 37° C. An aliquot of each hydrolysate with appropriate carriers 
(MIT, DIT, T4, I', 5 micrograms each) was subjected to descend¬ 
ing paper chromatography (Whatman No, 1) in the butanol-acetic 
acid solvent mentioned above. The distribution of radioactivity on 
the chromatograms was determined with an automatic scanning 
device equipped with a G-M counter. Areas under peaks were 
measured by planimetry and the percentage of radioactivity in each 
peak was calculated. 

RESULTS 
1 Q 1 
The percentage uptake for each time interval after I J 
injection was divided by the average thyroid weight of each such 
group to obtain the percentage uptake per milligram of thyroid 
tissue. The results are shown in Figure 2. 
1 Q1 
Figure 2. Uptake of I by the thyroid glands of rats 
1 O 1 
injected with Nal from 30 minutes to 72 hours before death. 




It can be seen that the uptake is maximal between 10 and 
20 hours. This maximum represents an uptake of about 8% for an 
average gland of weight 10 mg. This would indicate that the rats 
were receiving an adequate amount of iodine in the diet. Figure 
3 shows what percentage of the total uptake was in the ‘comparti- 
ment libre,' i.e., that which dialyzed at 0°C and, to another scale, 




















Figure 3. Distribution of radioactivity in the dialysates 
of rat thyroid glands from 30 minutes to 72 hours after the injec¬ 
tion of I1Radioactivity of the total dialysable iodine (-O-) and 
of the free iodo-organic fraction ( as percent of the total 
radioactivity of the glands. The curve (—^—) shows dialysable 
iodo-organic activity as percent of total dialyzed (scale on right). 
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It is seen that the total activity of the ‘compartiment 
libre’ diminishes monotonically as that proportion which is 
organic increases. Radioautographs of chromato-electrophor- 
etograms of the ‘compartiment libre’ of rat thyroid glands 1, 11, 
and 72 hours after I injection are shown in Figure 4. The 
diagram in lower right of Figure 4 is a schematic representation 
of the position after chromato-electrophoresis of the iodocom- 
pounds most frequently encountered as dialysable (or TCA- 
soluble) material in the thyroid. Besides MIT and DIT, 
lettering of these compounds was arbitrarily done from A to E 
beginning with those having the lower R^ in BA5. Compounds 
corresponding to spots labeled in lower case from a to e were 
not investigated in the present study. 
Iodocompounds of group A do not migrate in the BA5 
solvent system but are separated in electrophoresis. Those 
of group B have a chromatographic behavior roughly similar to 
that of MIT and DIT but different electrophoretic mobilities. The 
C group contains iodocompounds, the Rf of which is intermediate 
between 0 and that of inorganic iodide, and whose electrophoretic 















Autoradiographs of chromato-electrophoretographs of 
dialysates at 0 C. of rat thyroid glands 1, 11, and 72 hours after 
1^* injection. C is zone of deposition of the concentrated dialysate. 
Arrows indicate directions of migration in chromatography (BA5) 
and, for electrophoresis, the direction of the negative pole. The 
schematic drawing indicates the positions of the free iodocompounds 
most frequently encountered as dialysable material in rat thyroid 
gland. Compounds not labeled in the autoradiographs, or labeled 
lower case from a to e were not investigated in the present study. 
For explanation of other labeling, see text. 
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Peptides Bj and gave MIT and DIT on pancreatic 
hydrolysis. As they were also present in ox thyroid glands, their 
isolation in a pure form was accomplished according to a method 
previously described (19). Bj (ox) showed the following amino 
acid composition: aspartic acid, glutamic acid, serine, glycine, 
alanine, valine, phenylalanine, the leucines, tyrosine, MIT, and 
sometimes DIT. 
Studies done with and Cjj, labeled by 1^1 in vivo 
and purified by preparative chromato-electrophoresis on Whatman 
No. 3MM paper, indicated that Cjj is hydrolysable by pancreatin 
with difficulty, giving only MIT as a labeled product (Figure 5). 
Cj on hydrolysis yielded DIT and a compound migrating 
in the same position as Cjj in BA5 (Figure 5) and t-amylol 
saturated with 2N NH^OH (R^ =0). As does not migrate 
in alkaline organic systems but does migrate with iodide in 
butanol-acetic acid solvents, its detection is not usually accom¬ 
plished with ordinary chromatographic systems: its radioactivity 
is attributed to inorganic iodide. The other spots (A, E) were 
presumed to be iodopeptides as they gave MIT or MIT + DIT on 
pancreatic digestion. Further characterization of these compounds 
was not undertaken as their very low concentration precluded 
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isolation of a sufficient quantity. 
Figure 5. Scanning of the radioactivity of chromato¬ 
grams (BA5) done with pancreatic digests of iodocompounds Cj 
(above) and C^. (below). The concentrated dialysate of thyroid 
glands of rats injected with Nal^l (100 uc) 14 hours prior to 
sacrifice was analyzed by chromato-electrophoresis and auto¬ 
radiography. Areas corresponding to Cj and Cjj were cut in 
small pieces and digested with pancreatin. Solid bars indicate 
position of carriers (I", MIT, DIT); 0= origin, f= solvent front. 
Ordinate: radioactivity in counts/minute. Abscissa: length of 
chromatographic migration, one division corresponds to 1 cm. 
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The relative intensities of the chromato-electrophoretic 
spots of the dialysable radioactivity differ according to the time 
1 Q1 
elapsed after I injection (Figure 4). In order to quantify the 
concentration relationships between the various compounds, the 
following procedure similar to that proposed by Pitt-Rivers (16) 
for calculating estimated RSA was used. 
The radioactivity represented by each spot, as a percent¬ 
age of the total injected, was calculated by multiplying the fraction 
it represented of the radioactivity of the 'compartiment libre’ by 
the fraction the 'compartiment libre’ represented of the injected 
total. The assumption was made that at 50-72 hours after I131 
injection the ratio of IAJA to I in the labeled compounds had 
approached its equilibrium value. The assumption was supported 
by the fact that from 24 hours on, the proportion of radioactivity 
in each iodocompound is practically constant. It is evident, then, 
that at equilibrium the concentration of each iodocompound is 
proportional to its I*31 content. If, now, due to the lack of pre¬ 
cise knowledge of the concentration of the corresponding l^7_ 
iodocompound, the specific activity of each iodocompound at 
equilibrium is set equal to one, the specific activity at any given 
time relative to this final value can be calculated. 
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Accordingly, the relative specific activities of each of the 
free iodocompounds was calculated as a function of time, by dividing 
by the equilibrium percentage the percentage of the total injected 
radioactivity represented at each time by each free iodo-organic 
compound. The relative specific activities of bound MIT and 
bound DIT were calculated in the same manner from the percentage 
of MIT and DIT found at each time interval after I101 injection in 
the dialyzed pooled thyroid glands after pancreatic hydrolysis. 
(See Appendix section for mathematical definitions and sample 
calculations.) 
In Figure 6 curves comparing the relative specific 
activities of Cjj, free MIT, and bound MIT are plotted. It is 
seen that iodide taken up by the thyroid is first incorporated into 
iodopeptide Cjj and later into free and bound MIT. 
Figures 7 and 8 compare the relative specific activities 
of MIT and DIT in the‘compartiment libre’ with those of MIT and 
DIT in thyroglobulin. Note should be made of the differences in 
scale of the ordinates in these figures: the relative specific 
activities of the free iodotyrosines are much greater, at early 
time intervals after I131 injection, than those of MIT and DIT in 
thyroglobulin. It should also be noted that although the curves 
' 
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could be reasonably retraced to present the maxima of free and 
bound MIT in such a position as to imply by the criteria mentioned 
Figure 6. Estimated relative specific activities of 
iodopeptide Cjp free MIT (in the dialysates), and bound MIT 
(in the hydrolysates) of rat thyroid glands 30 minutes to 72 
hours after injection of I131. 
earlier (17) that it could be a precursor of DIT, respectively 
free and bound, it would seem more logical to conclude that 
since 1^1 js incorporated maximally into DIT sooner than 

21 
would be possible if newly formed MIT were its only precursor, 
Di 131 t does not arise solely from the iodination of MI*3^T. 
Figure 9 presents the RSA curves of various iodopeptides. 
The group labeled A represents at least five iodopeptides (Aq, Aj, 
Figure 7. Estimated relative specific activities of 
free MIT and DIT in the dialysates of rat thyroid glands from 
30 minutes to 72 hours after injection of I131. 
Ajp Ajij, Ajy, A Figure 4), the radioactivities of which were 
added to obtain their total RSA after it became evident that their 

specific activities taken separately showed identical behavior. 
Four components similarly compose the iodopeptide 
group B (Bp Bjp Bm, E). Their RSA curve is seen to be 
Figure 8. Estimated relative specific activities of 
bound MIT and DIT in the hydrolysates of rat thyroid glands 
from 30 minutes to 72 hours after injection of I^l# 
very similar to that of bound DIT. 
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The RSA curve of iodopeptides shows a form 
similar to that of group A but reaches its maximum at an earlier 
time. 
B 
Cj + cm 
A 
Figure 9. Estimated relative specific activities of 
iodopeptides groups B, Cj + C^, and A (in the dialysates) of 
rat thyroid glands from 30 minutes to 72 hours after 11 °1 injection. 
One interesting sidelight is that Cp and more often 
and in higher concentration Cp, are also noted in studies of 
thyroid slices incubated in vitro with Nal*^. Larger quantities 
of Cjj are formed when the slices are placed in conditions under 
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which they are unable to organify iodine or to form DIT. 
Although none of these iodopeptides has as yet been 
isolated in sufficient amount to permit more than token chemical 
investigation, suggestions as to their origin and composition can 
be drawn from their chromato-electrophoretic behavior and 
specific activity curves. The low migration of the iodopeptides 
of group A in BA5 (R^ = 0), their complete exclusion from 
dextran gel of high cross-linkage (Sephadex G-25) and the 
relative slowness with which they are labeled, suggest that they 
are rather large peptides (M. W. = 5,000 to 15,000) derived 
from thyroglobulin. The similarity in chromatographic and 
electrophoretic behavior and the remarkable similarity of the 
relative specific activity curves between iodopeptides B and 
bound DIT suggests that these iodopeptides are released from 
thyroglobulin not containing iodothyronines. 

DISCUSSION 
The finding that the radioactivity of the dialysable iodo 
compounds of the thyroid is highest at the shortest time intervals 
after I1^1 injection and then descends continuously seems to 
implicate free iodo compounds as primary intermediates in the 
biosynthesis of the thyroid hormones. Concerning their distri¬ 
bution in the 'compartiment libre, ’ it has been shown that the 
percentage radioactivity in the total free iodo-organic fraction 
increases in the same time and tends to plateau. 
The concurrent study of the estimated relative specific 
activities of the various compounds constituting this free iodo- 
organic fraction has demonstrated the following points: (1) iodo- 
compound Cjj, which appears to behave as an iodopeptide, 
reaches its maximum RSA (3-4 hours) before any other iodo- 
organic compound of the gland; (2) free MIT reaches its maxi¬ 
mum RSA after C^ (7-8 hours) and nearly at the same time as 
free DIT (9-10 hours); (3) thyroglobulin-bound MIT attains its 
maximum RSA 5 to 6 hours after that of free MIT, confirming 
the recent findings of Pitt-Rivers and Cavalieri (18). The value 
of the maximum RSA is higher for Cjj than for free MIT, which 
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is in turn higher than that of bound MIT. The RSA of the group 
of peptides B reaches its maximum value approximately at the 
same time as bound DIT, in contrast to the peptides A and Cj + C^, 
the RSA of which increases up to 72 hours, suggesting that they 
derive from the proteolysis of thyroglobulin. 
According to the classical scheme, serum inorganic 
iodide trapped by the thyroid cell ('first iodide pool’) is very 
rapidly and sequentially organified in thyroglobulin into first MIT 
and then DIT. These residues are presumably the precursors 
of thyroglobulin-iodothyronines in a coupling reaction. Non¬ 
perchlorate-dischargeable iodide has been recently assumed to 
constitute a second iodide pool (22) coming from the deiodination 
of free iodotyrosines split off during proteolysis of thyroglobulin 
and with a lower turnover rate than that of iodide in the first pool. 
Our results showing a high value for the relative specific 
activity of iodopeptide and free MIT at early time intervals 
after I1^ injection may be interpreted within the framework of 
this scheme if it is postulated that a thyroglobulin fraction exists 
with a high turnover rate, different from storage thyroglobulin in 
the colloid. Proteolysis of this fraction would give rise to C 
from which, in turn, free MIT and perhaps free DIT would be 
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produced; a possible function of might be that in this form 
MIT is protected from intrathyroidal deiodinase. 
However, another hypothesis would explain the experi¬ 
mental data: a precursor of Cjj could be directly iodinated from 
the inorganic iodide trapped from the serum, giving rise to C-^. 
Cjj and its product, free MIT could be direct precursors of thyro- 
globulin. Pitt-Rivers and Cavalieri (18) have already suggested 
that free tyrosine could be iodinated in the gland to explain the high 
RSA of free MIT as compared to bound MIT. The similarity 
between the RSA curves of free MIT and free DIT is more difficult 
to interpret (see RESULTS section), as the present data do not 
permit a choice between the following immediate precursors of 
free DIT: free MIT just formed, preformed free MIT, Cjp tyrosine, 
or a small tyrosine peptide. 
Since these hypotheses on the intermediate metabolism 
of the thyroid hormones concern amino acids which are eventually 
incorporated into thyroidal proteins, an integration of these hypo¬ 
theses with present-day theories of protein synthesis would be 
desirable. There has been radioautographic evidence (24) that 
iodination and protein synthesis do not take place in the same part 
of the thyroid acinus nor with the same time course. Other workers 
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(25, 26) using isolated thyroid cells have concluded that iodination 
probably takes place within the cell. The following discussion 
assumes that it is most likely that protein synthesis and iodination 
take place within the cell prior to the secretion of the final products 
into the follicular colloid. 
Let us look first at the fundamental necessities of protein 
synthesis, amino acid activating enzymes and soluble ribose 
nucleic acids, insofar as they apply to thyroidal iodo-amino acids. 
Herzfeld (27) using sheep thyroid pH 5 preparations 
found active pyrophosphate (P22) exchange into ATP in the presence 
of tyrosine and MIT and other amino acids, but not with DIT. He 
was unable to isolate amino acyl-sRNA. Alexander (2 8) has also 
noted that L-tyrosine and MIT enhanced PP-ATP exchange and 
that this reaction was not shown or was inhibited by DIT, Tq, T^ 
and T^. He also found that tyrosyl hydroxamate formation was 
inhibited by excesses of MIT and DIT, whereas thyronines and 
iodothyronines were without effect. He isolated tyrosyl-sRNA 
from incubation mixtures of crude thyroid tissue supernates. 
Attempts (29) to demonstrate direct incorporation of iodothyronines 
by partially purified thyroidal systems consisting of calf thyroid 
amino acid activating enzymes and sRNA with both rat and dog 
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liver and calf thyroid ribosomes have been unsuccessful. 
From these reports it seems likely that thyroid tissue 
possesses an amino acid activating enzyme for MIT and possibly 
for DIT and that it might be identical with that for tyrosine. The 
implication of this for thyroglobulin synthesis is that preformed 
free MIT and DIT could be incorporated as are the non-iodinated 
amino acids in the formation of thyroglobulin. MIT and DIT could 
also be incorporated into thyroglobulin by another route; activated 
tyrosine transferred to sRNA could be iodinated while in that 
combination and then incorporated as MIT and DIT into protein. 
These compounds, isolated in dialysates as MIT-sRNA and 
DIT-sRNA would tend to be unstable and decompose in acidic 
chromatographic solvents to yield ‘free’ MIT and DIT. The 
present RSA data are compatible with either mechanism, a choice 
between the two depending on the rate of amino acid transfer to 
protein relative to the rate of formation of the iodotyrosyl-sRNA. 
If the rate of transfer of amino acids by the iodotyrosyl-sRNA 
intermediate were relatively rapid the former mechanism would 
tend to be favored, while the latter would be more likely if that 
rate were shown to be relatively slower. 
How, then, are T^ and T^ formed? Given that MIT and 
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DIT are coupled with DIT to form Tg and what are the forms of 
the reacting species? Prior to the discovery (21) of free MIHPPA 
and DIHPPA in thyroid tissue the most likely hypothesis was that 
random apposition of iodotyrosine residues contained in thyro- 
globulin resulted in iodothyronine formation, leaving an ‘extra’ 
serine or similar residue to mark the site of the ^C-ring (outer 
ring) donor. However, no analysis of thyroglobulin amino acid 
composition has shown the expected (30) 2 extra residues per 
mole. The experiment of comparing amino acid analyses of 
thyroglobulin for serine or a similar residue when Tg and 
formation have been suppressed by thiocarbamide administration 
or iodide deprivation with the amino acid composition when Tg 
and formation are permitted has never been performed. 
Another hypothesis combining old with newer evidence 
would be that the reacting intermediates are the thyroglobulin- 
bound iodotyrosines and their iodohydroxyphenylpyruvate 
derivatives. If, as the present data and those of Pitt-Rivers (16) 
would indicate, the maximum RSA values of bound DIT and T^, 
and bound MIT and Tg, respectively, are nearly contempora¬ 
neous, this would preclude the thyroglobulin-bound iodotvrosines 
as precursors of iodothyronines. Indeed, it would appear to 
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imply that these two compounds share the same precursor(s), 
most likely the respective iodotyrosine-sRNA compounds, the 
MIT-sRNA and DIT-sRNA referred to above. 
Diiodohydroxyphenylpyruvate has been shown to combine 
aerobically with DIT to form thyroxine (31, 32, 33). Peptides 
containing DIT can replace free DIT to yield thyroxine-containing 
peptides. These aerobic enzymatic and non-enzymatic conden¬ 
sations in vitro suggest that free DIHPPA and MIHPPA donate 
the (X-ring to the iodotyrosyl-sRNA precursors of the thyroidal 
thyronines T^ and T^. DIHPPA and MIHPPA probably arise in 
thyroid tissue from free DIT and MIT through transamination 
with -ketoglutarate or perhaps through L-amino acid oxidase, 
the possibility also exists that 4-hydroxyphenylpyruvic acid (HPPA)t 
formed from tyrosine by the reactions) above, is directly 
iodinated to MIHPPA and DIHPPA by iodide ion in a non-oxidative 
mechanism similar to the one in Figure 10. 
That MIT-sRNA could also intervene in the biosynthetic 
process, to take the place of DIT-sRNA in combining with the 
iodohydroxyphenylpyruvates is suggested by the finding of small 
quantities of Tg (5, 34, 35) and 3,3',5’-Tg (34, 35) in hydrolysates 
of thyroid tissue. 
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A possible explanation for the low concentration of these 
compounds lies partially in the relatively lower concentrations of 
OH 
CH 












Figure 10. Possible mechanism for the formation of 
iodohydroxyphenylpyruvates showing iodination of 4-hydroxyphenyl- 
pyruvate by iodide ion. Unlabeled compounds are hypothetical 
reaction intermediates. (For other mechanisms see text.) 
the free monoiodinated precursors. Probably more importantly, 
the absence of one of the ortho-halogens on the benzene ring in 
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MIT would make the ‘phenozide* ion less electronegative, result¬ 
ing in decreased activation for nucleophilic substitution at the 1 
position in the iodohydroxyphenylpyruvates and lowering the 




c = 0 
/ 
Figure 11. Possible mechanism for the general ‘coupling* 
reaction leading to the formation of the iodothyronines. Shown is 
a condensation between 3,5-diiodotyrosine and 3-iodo-4-hydroxy- 
phenylpyruvic acid forming 3,5,3’-triiodothyronine. A sulfur 
enzyme or co-enzyme (indicated R-S-) is included for reasons 
explained in the text. 
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shows a possible mechanism for the coupling reaction forming the 
diphenyl ether from the iodotyrosines and the iodohydroxyphenyl- 
pyruvates. Although unnecessary in vitro, a sulfur enzyme or 
co-enzyme is shown in the mechanism, as such an intermediate 
could facilitate the in vivo reaction by allowing distribution of 
negative charge onto the carboxyl oxygen. 
In Figure 12 some of the thyroidal biosynthetic pathways 
proposed in this paper are pictorially combined. The iodination 
of either free tyrosine or tyrosyl-sRNA is suggested by the 
alternate pathways a, b or a', b’, c', respectively. The iodinating 
species is shown as I+; for the sake of clarity the mechanism 
elaborated in Figure 11, that the iodohydroxyphenylpyruvates, 
and thence the iodotyrosines, might be formed by iodination of 
hydroxyphenylpyruvic acid with iodide ion,is not included. 
The coupling reaction between the iodotyrosyl-sRNA 
compounds and the iodohydroxyphenylpyruvates is indicated by 
the four dashed lines. Solid arrows indicate other reactions, 
with no implication as to reversibility of reaction. Thyroglobulin- 
bound amino-acids, shown in the right-hand column, have been 
isolated from mammalian thyroid tissue, as have the free iodo¬ 
hydroxyphenylpyruvates, free amino acids and tyrosyl-sRNA. 
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Presumptive evidence for the presence of MIT-sRNA and weaker 
presumptive evidence for DIT-sRNA has been presented. 
Figure 12. Possible pathways for the biosynthesis of 
the thyroid hormones. Abbreviations explained in text**; tg- means 
thyroglobulin bound. Condensation reactions suggested by dashed 
lines, all others by solid line. Letters a, b, c, d, and a’, b’, c’ 
indicate two alternate pathways for organification of iodine and 
amino acid transfer to sRNA. An explanation for the relative pre¬ 
ponderance of condensations e, f over e’, f’ is given in the text. 

SUMMARY 
The time course of appearance in rat thyroid glands 
after single injection of I1"* as total thyroidal iodine, free iodide, 
free Iodo-organic fractions and bound iodo-organic compounds 
has been investigated by the method of dialysis and chromato- 
electrophoresis (20). The relative specific activities of free 
MIT, free DIT, various free iodopeptides, bound MIT, and bound 
DIT have been determined. It has been shown that the most highly 
1 O 1 
labeled iodocompound at early times after IAOA injection is a 
consistently isolated free iodopeptide. Following in rapidity 
and extent of labeling are free MIT and free DIT; the RSA 
maxima for the thyroglobulin-bound iodotyrosines follow that of 
the free species by 5-6 hours. 
The present data corroborate the experimental findings 
of Pitt-Rivers (16) and others (14) with respect to the activity- 
1 O 1 
time relationships of IA° labeling of thyroglobulin-bound MIT 
and DIT; the findings of Bois and Larsson (15) that the MI13*T/ 
DI131T ratio remains constant for one week after I1^1 injection 
are therefore not confirmed. Mechanisms (see Figures 11 and 
12) are offered for the biosynthesis of thyroxine and triiodo- 
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thyronine in rat thyroid gland. On the basis of these hypotheses 
the findings of Pitt-Rivers (16) that RSA curves for Tg and 
were similar in shape and maxima to those of thyroglobulin- 
bound MIT and DIT, respectively, find an explanation. Studies 
(10, 11) showing random labeling of I^1 in both rings of Tg and 
T4 isolated from rabbit thyroid can be interpreted in the light of 
these hypotheses and the present experimental findings, although 
definite conclusions cannot be drawn until data regarding the rate 
of attainment of isotopic equilibrium in rabbit thyroid gland 













x p MIT 
(t) ' (t) 
etc. 
the percentage uptake of injected 
I^^/mg thyroid tissue, 
the percentage thyroidal radioac¬ 
tivity in the ‘compartiment libre, ’ 
the percentage free radioactivity 
in the iodo-organic fraction of the 
‘compartiment libre,’ 
the percentage radioactivity in 
each component compound of the 
free iodo-organic fraction, and 
the percentage of the total injected 
radioactivity represented by each 
free iodo-organic compound. 
I Q 1 
Then, for any given time interval after I injection, denoted by 
the subscript (t), one can relate the measured datum, r^x, *° 






Since, at equilibrium, the percentage radioactivity of any free iodo- 
organic compound relative to the injected total becomes proportional 
X 
to its representation in the stable, unlabeled form, divided 
ky p(t=equilibrium) ’ (defined as 
p x_p = p x 4. p x/2 
(t=equilibrium) (eq) (t=50) (t = 72) 
for reasons explained in the text) is proportional to the specific 





where K is constant; 
Relative SA 
To give a numerical example, with x = MIT, for the time interval 
6 hours after injection of i^l (data from Table 2): 
p MIT _ _ MIT v- v tt vo 
(6) ' (6) X (6) X F(6) X °(6) 
P(6)MIT = 13.4 X (0.65 X 10‘2)(2.4 X 10~2)(39.0 X 10'2) 
= 8.1 X 10‘4 
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P^MIT = p,5o/1IT + f',72^ 
MIT 
(eq) 
 0.00034 + 0.00031 









3.2 X 10 -4 
TABLE 2 
P(t)x AND RELATIVE SPECIFIC ACTIVITY CALCULATED 
FROM C, F, O, AND r(t)x. DATA FOR 6, 50, AND 
72 HOURS AFTER Nal131 INJECTION. 
Percentage radioactivity Iodo compound 
Iodo peptides group 
(hrs ) F C 0 MIT DIT Ci + Cm Ci i A B 

























































P(C9)X 0.00032 0.00087 0.00027 0.000032 0.00056 0.000065 
(a) r(t)X Value, (b) P^x Value, (c) Relative SA^X. 
Note; Abbreviations C, F, O, r(t)x# P(t)X* anc* SA^X as 







Post-Sophomore Research Fellow of the National Institutes of 
Health, United States Public Health Service, during the period 
of laboratory investigation at the Laboratoire de Biochimie 
Medicale, Faculte de Medecine et de Pharmacie, Marseille, 
France. 
2 
Abbreviations: MIT, 3-iodotyrosine; DIT, 3,5-diiodotyrosine; 
T2, 3,3’-diiodothyronine; Tg, 3,5,3*-triiodothyronine; Tg’, 
3,3’,5’-triiodothyronine; T^, thyroxine; MIHPPA, 3-iodo- 
4-hydroxyphenylpyruvic acid; DIHPPA, 3,5-diiodo-4-hydroxy- 
phenylpyruvic acid; ATP, adenosine triphosphate; sRNA, 
soluble ribosenucleic acid; BA5, 1-butanol--acetic acid-- 
water (78:5:17); RSA, relative specific activity. 
3 
Throughout this paper the adjective ‘bound’ will imply that 
the compound under consideration is contained in a peptide 
sequence and liberated only by enzymatic digestion. 
4 
That portion of this paper dealing with the experimental 
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investigation has been published (36) as a communication 
from the laboratory noted above. 
5 
Dilutine 140 is the trade name of Shell-Berre for a light 
petroleum ether fraction (flash point 70°C). 
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